
Sign up to save your podcasts
Or


Send us a text
In this episode of the Hotflash Inc Podcast, host and journalist Ann Marie McQueen is joined by Dr. Rachel Pope, an OB-GYN and certified menopause practitioner at the Institute University Hospitals Cleveland, with an appointment in the Department of Reproductive Biology. Dr. Pope is also a public health researcher, currently working to clarify gaps in hormone therapy research that impact real women every day.
Dr. Pope’s recent study set social media on fire, with claims that hormone therapy in perimenopause reduces breast cancer, stroke, and heart attack risk by 60%. But is that actually what the data said? In this episode, Dr. Pope gives a clear, honest account of what her study really found – and what it didn’t. She speaks about the confusion that followed, why nuance matters, her belief in the power of hormone therapy and how to move forward in the menopause conversation with more care, accuracy and integrity.
This is a must-listen for anyone navigating perimenopause, hormone therapy decisions or working in the midlife health space.
Sponsor Shoutout
Thank you to our sponsor, Timeline Nutrition – makers of Mitopure™, the first clinically tested Urolithin A supplement that supports cellular energy and muscle strength. Visit www.timeline.com and use the code HOTFLASH for 20% off your first order.
Thank you to Bonafide, a gold sponsor at the Hotflash Inc Summit. To learn more, visit hellobonafide.com and be sure to use code SUMMIT20 to receive 20% off the first month of any Bonafide subscription product.
Highlights
GUEST LINKS
Join the Hotflash inc perimenoposse:
Web: hotflashinc.com
Newsletter: Hotflash inc. on Substack
TikTok: @hotflashinc
Instagram: @hotflashinc
X: @hotflashinc
Episode website: Hotflashinc
Listen on: Apple Podcasts | Spotify | Google Podcasts | YouTube | Substack
See hotflashinc.com/privacy-policy for privacy information
By Hotflash inc4.7
2525 ratings
Send us a text
In this episode of the Hotflash Inc Podcast, host and journalist Ann Marie McQueen is joined by Dr. Rachel Pope, an OB-GYN and certified menopause practitioner at the Institute University Hospitals Cleveland, with an appointment in the Department of Reproductive Biology. Dr. Pope is also a public health researcher, currently working to clarify gaps in hormone therapy research that impact real women every day.
Dr. Pope’s recent study set social media on fire, with claims that hormone therapy in perimenopause reduces breast cancer, stroke, and heart attack risk by 60%. But is that actually what the data said? In this episode, Dr. Pope gives a clear, honest account of what her study really found – and what it didn’t. She speaks about the confusion that followed, why nuance matters, her belief in the power of hormone therapy and how to move forward in the menopause conversation with more care, accuracy and integrity.
This is a must-listen for anyone navigating perimenopause, hormone therapy decisions or working in the midlife health space.
Sponsor Shoutout
Thank you to our sponsor, Timeline Nutrition – makers of Mitopure™, the first clinically tested Urolithin A supplement that supports cellular energy and muscle strength. Visit www.timeline.com and use the code HOTFLASH for 20% off your first order.
Thank you to Bonafide, a gold sponsor at the Hotflash Inc Summit. To learn more, visit hellobonafide.com and be sure to use code SUMMIT20 to receive 20% off the first month of any Bonafide subscription product.
Highlights
GUEST LINKS
Join the Hotflash inc perimenoposse:
Web: hotflashinc.com
Newsletter: Hotflash inc. on Substack
TikTok: @hotflashinc
Instagram: @hotflashinc
X: @hotflashinc
Episode website: Hotflashinc
Listen on: Apple Podcasts | Spotify | Google Podcasts | YouTube | Substack
See hotflashinc.com/privacy-policy for privacy information

178 Listeners

9,198 Listeners

333 Listeners

133 Listeners

607 Listeners

391 Listeners

1,091 Listeners

117 Listeners

377 Listeners

211 Listeners

140 Listeners

92 Listeners

120 Listeners

407 Listeners

65 Listeners